Blog
-
Abcam’s shares receive mixed opinions
Just a few weeks ago we reported that equity research organisation Berenberg had changed...September 5, 2018 -
CiteAb data helps put Abcam back on Berenberg’s buy list
After being downgraded just three months ago by equity research organisation Berenberg, Abcam has...August 9, 2018 -
Santa Cruz maintain position in secondary antibody market
If you’ve followed our blog for a while you’ll know we like to make...August 2, 2018 -
Which were the leading antibodies of 2017?
Today we’re looking at the data we collated for antibody citations throughout the whole...July 12, 2018 -
Should you reconsider your ‘go-to’ chemical probe?
Do you have a tendency to go back to the chemical probe you know...July 11, 2018 -
Where should antibody suppliers focus their European marketing?
Today our new data snapshot sheds light on the European antibody market, and should...May 24, 2018 -
How our instrument data shows which products stand the test of time
A few weeks ago we posted on our blog about a brand new type...April 4, 2018 -
Exciting new data area to explore through CiteAb
Those of you who have known CiteAb from the beginning will be aware that...March 16, 2018 -
Which suppliers are cracking China’s chemical probes market?
Two weeks ago we published a blog looking at our new chemical probes data,...March 13, 2018
